During the past decade, Lubelskie Centrum Diagnostyczne conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lubelskie Centrum Diagnostyczne" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Anika Therapeutics, Inc." with 2 trials sponsored, "IBSA Institut Biochimique SA" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lubelskie Centrum Diagnostyczne" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lubelskie Centrum Diagnostyczne" are "Knee Osteoarthritis" (4 trials), "Psoriasis" (4 trials), "Arthritis, Psoriatic" (3 trials), "Endometriosis" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Lubelskie Centrum Diagnostyczne" in a lesser frequency.

Most popular intervention types in "Lubelskie Centrum Diagnostyczne" are "Drug" (24 trials), "Device" (5 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (4 trials), "Mirikizumab" (3 trials), "200 mg linzagolix tablet" (2 trials) and "75 mg linzagolix tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lubelskie Centrum Diagnostyczne" are 21 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lubelskie Centrum Diagnostyczne". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Lubelskie Centrum Diagnostyczne, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lubelskie Centrum Diagnostyczne, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".